Jeffrey Meisner
About Jeffrey Meisner
Jeffrey Meisner serves as the Director of Translational Medicine at Locus Biosciences, Inc. in Morrisville, North Carolina, a position he has held since 2022, following a career that includes roles at Kaleido Biosciences and Emory University.
Current Role at Locus Biosciences
Jeffrey Meisner serves as the Director of Translational Medicine at Locus Biosciences, Inc., a position he has held since 2022. He is based in Morrisville, North Carolina. In this role, he focuses on bridging the gap between laboratory research and clinical applications, facilitating the development of innovative therapies.
Previous Experience at Kaleido Biosciences
Before joining Locus Biosciences, Jeffrey Meisner worked at Kaleido Biosciences in various capacities. He started as a Scientist from 2017 to 2019, then advanced to Senior Scientist from 2019 to 2020. Following this, he held the position of Associate Director, Biology from 2020 to 2022. His tenure at Kaleido was marked by contributions to the development of microbiome-based therapies.
Postdoctoral Research Background
Jeffrey Meisner has a solid foundation in research, having completed two postdoctoral fellowships. He was a Postdoctoral Fellow at Emory University from 2013 to 2017 and at Harvard Medical School from 2011 to 2013. These experiences provided him with extensive training in microbiology and molecular genetics.
Educational Qualifications
Jeffrey Meisner earned a Bachelor of Science degree in Pharmacology from the University of California, Santa Barbara in 2010. He further pursued his education at Emory University, where he obtained a Doctor of Philosophy (PhD) in Microbiology and Molecular Genetics. His academic background supports his expertise in translational medicine.